Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofer Nativ

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Clinical Genitourinary Cancer|November 28, 2017
Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell CancerAsaf Shvero, Ofer Nativ, Yasmin Abu-Ghanem, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 17, 2009
A novel human heparanase splice variant, T5, endowed with protumorigenic characteristicsUri Barash, Victoria Cohen-Kaplan, Gil Arvatz, et al.
European Urology|January 25, 2016
Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder CancerTom J H Arends, Ofer Nativ, Massimo Maffezzini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2003
Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder: a phase I and pharmacokinetic studyMenachem Laufer, Sakkaraiappan Ramalingam, Mark P Schoenberg, et al.
American Journal of Physiology. Renal Physiology|February 1, 2013
Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1Rima Sohotnik, Omri Nativ, Abeer Abbasi, et al.
European Urology Focus|July 30, 2017
A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation StudyNoa Davis, Alexander Shtabsky, Sylvia Lew, et al.
Bladder Cancer (Amsterdam, Netherlands)|November 13, 2018
Intravesical Radiofrequency-Induced Chemohyperthermia for Carcinoma <i>in Situ</i> of the Urinary Bladder: A Retrospective Multicentre StudyF Johannes P van Valenberg, Amir Kajtazovic, Giorgio Canepa, et al.
Harefuah|May 23, 2017
[KIDNEY DISEASES IN NORTH ISRAEL ACCORDING TO KIDNEY BIOPSIES - BNAI-ZION MEDICAL CENTER 14 YEARS' EXPERIENCE]Shimon Storch, Nadav Willner, Aurora Toubi, et al.
Oncogene|October 25, 2003
Molecular analysis of transitional cell carcinoma using cDNA microarrayOrna Mor, Ofer Nativ, Avi Stein, et al.
Nature Biotechnology|March 26, 2008
MicroRNAs accurately identify cancer tissue originNitzan Rosenfeld, Ranit Aharonov, Eti Meiri, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Clinical Genitourinary Cancer|November 28, 2017
Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell CancerAsaf Shvero, Ofer Nativ, Yasmin Abu-Ghanem, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 17, 2009
A novel human heparanase splice variant, T5, endowed with protumorigenic characteristicsUri Barash, Victoria Cohen-Kaplan, Gil Arvatz, et al.
European Urology|January 25, 2016
Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder CancerTom J H Arends, Ofer Nativ, Massimo Maffezzini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2003
Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder: a phase I and pharmacokinetic studyMenachem Laufer, Sakkaraiappan Ramalingam, Mark P Schoenberg, et al.
American Journal of Physiology. Renal Physiology|February 1, 2013
Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1Rima Sohotnik, Omri Nativ, Abeer Abbasi, et al.
European Urology Focus|July 30, 2017
A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation StudyNoa Davis, Alexander Shtabsky, Sylvia Lew, et al.
Bladder Cancer (Amsterdam, Netherlands)|November 13, 2018
Intravesical Radiofrequency-Induced Chemohyperthermia for Carcinoma <i>in Situ</i> of the Urinary Bladder: A Retrospective Multicentre StudyF Johannes P van Valenberg, Amir Kajtazovic, Giorgio Canepa, et al.
Harefuah|May 23, 2017
[KIDNEY DISEASES IN NORTH ISRAEL ACCORDING TO KIDNEY BIOPSIES - BNAI-ZION MEDICAL CENTER 14 YEARS' EXPERIENCE]Shimon Storch, Nadav Willner, Aurora Toubi, et al.
Oncogene|October 25, 2003
Molecular analysis of transitional cell carcinoma using cDNA microarrayOrna Mor, Ofer Nativ, Avi Stein, et al.
Nature Biotechnology|March 26, 2008
MicroRNAs accurately identify cancer tissue originNitzan Rosenfeld, Ranit Aharonov, Eti Meiri, et al.
Pageof 9